PMMNG member Phil Falkowitz started taking Revlimid (lenalidomide) way back in 2001, during the Phase 1 clinical trial of Revlimid. That trial went well for him (and for Revlimid).
I was a 49 year-old father of five adolescent kids with a demanding job and a time-consuming commute when I was diagnosed with MM in 2003. That news, delivered clumsily by my hematologist, left me shell-shocked in his waiting room for over an hour. Nothing gets your attention like a mid-life reminder of your mortality.